Central Trust Company’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Central Trust Company’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4	Closed	–	–	1298
2018 Q3	$0	Hold	4	–	–	﹤0.01%	1328
2018 Q2	$0	Hold	4	–	–	﹤0.01%	1372
2018 Q1	$0	Hold	4	–	–	﹤0.01%	1366
2017 Q4	$0	Hold	4	–	–	﹤0.01%	1414
2017 Q3	$0	Hold	4	–	–	﹤0.01%	1404
2017 Q2	$0	Hold	4	–	–	﹤0.01%	1339
2017 Q1	$0	Sell	4 -50	-93%	-$29	﹤0.01%	1233
2016 Q4	$0	Hold	54	–	–	﹤0.01%	1215
2016 Q3	$0	Hold	54	–	–	﹤0.01%	1202
2016 Q2	$0	Hold	54	–	–	﹤0.01%	1184
2016 Q1	$0	Buy	54 +50	+1,250%	+$34	﹤0.01%	1193
2015 Q4	$0	Hold	4	–	–	﹤0.01%	1232
2015 Q3	$0	Hold	4	–	–	﹤0.01%	1272
2015 Q2	$0	Buy	+4	New	+$8	﹤0.01%	1246

Central Trust Company's BTX.WS Position: Q4 2018 in Review

Central Trust Company sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2018, closing a stake of 4 shares.

Central Trust Company first reported a position in BTX.WS in Q2 2015 and held it in 14 quarters. The position peaked at $0 in Q3 2018. 0 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2018.

Central Trust Company reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2018 after selling out during the quarter.
Central Trust Company sold 4 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2018.
Central Trust Company first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q2 2015 and held it in 14 quarters.
Central Trust Company's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q3 2018.
0 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2018.

Based on Central Trust Company's 13F filing for Q4 2018, filed 8 Jan 2019.